SCHEMBL1998758

SCHEMBL1998758

CCNCC(c1ccc(-c2ccc(F)cc2)c(C)c1)c1cn[nH]c1-c1ccco1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 2/20 0.33
FGFR2 P21802 1/20 0.33
MAPT P10636 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
PIK3CA P42336 2/20 0.32
ADORA2A P29274 1/20 0.32
PIK3R1 P27986 1/20 0.32
ROCK2 O75116 1/20 0.32
ROCK1 Q13464 1/20 0.32
MAPK14 Q16539 3/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
HTR1A P08908 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1998051 0.85 MAPT (0.35) MAPTL3MBTL1SMN1; SMN2NPC1MAPK1
SCHEMBL2003305 0.85 MAPT (0.34) TGFBR1MAPTL3MBTL1SMN1; SMN2NPC1
SCHEMBL2006339 0.79 LMNA (0.44) TGFBR1MAPTPDE3BPDE3AALDH1A1
SCHEMBL2001550 0.77 MAPT (0.37) TGFBR1MAPTL3MBTL1SMN1; SMN2NPC1
SCHEMBL2000118 0.73 KCNH2 (0.33) TGFBR1MAPTL3MBTL1SMN1; SMN2NPC1
SCHEMBL2007396 0.71 ADORA2A (0.35) TGFBR1MAPTL3MBTL1SMN1; SMN2NPC1
SCHEMBL2001837 0.69 LMNA (0.43) MAPTL3MBTL1ALDH1A1LMNAHTT
SCHEMBL1998048 0.69 MAPT (0.36) TGFBR1MAPTL3MBTL1SMN1; SMN2NPC1
SCHEMBL5745204 0.68 LMNA (0.36) TGFBR1MAPTMAPK1PIK3CAPIK3R1
SCHEMBL2761238 0.68 LMNA (0.51) MAPTMAPK1ALDH1A1LMNAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960413-B2 Pyrazole compounds MERCK PATENT GMBH (DE) 2011-06-14 US disclosed
US-20060276650-A1 Pyrazole compounds MERCK PATENT GMBH (DE) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276650-A1 Pyrazole compounds HTR1D, HTR1A, HTR3A TGFBR1 1021/4885FGFR2 3595/4885MAPT 2121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.